10-Q Filing

ACUTUS MEDICAL, INC. CIK: 1522860 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001564590-20-053665`
Period End Date	20200930
Filing Date	20201113
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	afib-20200930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 70 Cash Flow Statement 94 Stockholders Equity 38

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$58.30M	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`TemporaryEquitySharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.45M	USD	Point-in-time
Marketable securities, short-term	`MarketableSecuritiesCurrent`	$99.74M	USD	Point-in-time
Marketable securities, short-term	`MarketableSecuritiesCurrent`	$62.35M	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$150.00K	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$150.00K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$263.00K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$1.89M	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$10.93M	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$8.42M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.63M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.82M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$82.46M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$175.65M	USD	Point-in-time
Marketable securities, long-term	`MarketableSecuritiesNoncurrent`	$8.79M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$9.94M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.43M	USD	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$1.84M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$2.34M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	695,902.00	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$3.78M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.11M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	27.83M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	26.72M	shares	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	695,902.00	shares	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	27.83M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$482.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$95.00K	USD	Point-in-time
Total assets	`Assets`	$105.45M	USD	Point-in-time
Total assets	`Assets`	$212.51M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.72M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.88M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$6.50M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$10.08M	USD	Point-in-time
Contingent consideration, short-term	`ShorttermContingentConsideration`	$4.00M	USD	Point-in-time
Contingent consideration, short-term	`ShorttermContingentConsideration`	$8.20M	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$833.00K	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$907.00K	USD	Point-in-time
Common and preferred stock warrant liability	`CommonAndPreferredStockWarrantLiability`	$8.92M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$16.13M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$31.91M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$2.05M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$1.36M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$38.76M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$38.24M	USD	Point-in-time
Contingent consideration, long-term	`LongtermContingentConsideration`	$3.60M	USD	Point-in-time
Contingent consideration, long-term	`LongtermContingentConsideration`	$5.70M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$8.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$77.91M	USD	Point-in-time
Total liabilities	`Liabilities`	$59.87M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized as of September 30, 2020 and no shares authorized as of December 31, 2019; no shares issued and outstanding as of each of September 30, 2020 and December 31, 2019, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized as of September 30, 2020 and no shares authorized as of December 31, 2019; no shares issued and outstanding as of each of September 30, 2020 and December 31, 2019, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 260,000,000 shares authorized as of each of September 30, 2020 and December 31, 2019; 27,826,408 and 695,902 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$28.00K	USD	Point-in-time
Common stock, $0.001 par value; 260,000,000 shares authorized as of each of September 30, 2020 and December 31, 2019; 27,826,408 and 695,902 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$33.25M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$484.16M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-331.61M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-259.03M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$67.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-30.00K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$152.64M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-131.82M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-263.97M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-206.71M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-175.45M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$212.51M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$105.45M	USD	Point-in-time

Income Statement 70 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$646.00K	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.17M	USD	3 Qtrs
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$5.89M	USD	3 Qtrs
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.17M	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$5.14M	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$11.00M	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$2.27M	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$6.88M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$5.87M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$24.49M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$8.34M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$15.49M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$35.19M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$15.83M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$19.00M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$7.98M	USD	1 Quarter
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$118.00K	USD	1 Quarter
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$700.00K	USD	3 Qtrs
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$700.00K	USD	1 Quarter
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$-1.47M	USD	3 Qtrs
Total costs and operating expenses	`OperatingCostsAndExpenses`	$29.43M	USD	1 Quarter
Total costs and operating expenses	`OperatingCostsAndExpenses`	$57.06M	USD	3 Qtrs
Total costs and operating expenses	`OperatingCostsAndExpenses`	$69.22M	USD	3 Qtrs
Total costs and operating expenses	`OperatingCostsAndExpenses`	$31.81M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-26.26M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-31.16M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-63.33M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-54.90M	USD	3 Qtrs
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$5.55M	USD	3 Qtrs
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$3.68M	USD	1 Quarter
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$608.00K	USD	3 Qtrs
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$3.00K	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-49.00K	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.45M	USD	3 Qtrs
Interest income	`InterestAndOtherIncome`	$525.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$23.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$733.00K	USD	3 Qtrs
Interest income	`InterestAndOtherIncome`	$393.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.37M	USD	1 Quarter
Interest expense	`InterestExpense`	$20.91M	USD	3 Qtrs
Interest expense	`InterestExpense`	$4.09M	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.39M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-9.25M	USD	3 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-5.03M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-22.23M	USD	3 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-921.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-31.29M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-32.09M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-77.12M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-72.58M	USD	3 Qtrs
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-9.00K	USD	1 Quarter
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$47.00K	USD	3 Qtrs
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-50.00K	USD	3 Qtrs
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$40.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$78.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-57.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-45.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$147.00K	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-77.14M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-32.09M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-31.22M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-72.48M	USD	3 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.95	USD	1 Quarter
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-115.66	USD	3 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-12.36	USD	3 Qtrs
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-47.21	USD	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	666,823.00	shares	3 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.87M	shares	3 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	679,591.00	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	16.08M	shares	1 Quarter

Cash Flow Statement 94 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-72.58M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-77.12M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$1.68M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$500.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$1.75M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$800.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$330.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$125.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$100.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$100.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$2.17M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$9.27M	USD	3 Qtrs
Amortization of premiums/(accretion of discounts) on marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$100.00K	USD	3 Qtrs
Amortization of premiums/(accretion of discounts) on marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-113.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$518.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$17.44M	USD	3 Qtrs
Amortization of right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$470.00K	USD	3 Qtrs
Amortization of right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$507.00K	USD	3 Qtrs
Research and development - license acquired	`ResearchAndDevelopmentInProcess`	$15.00M	USD	3 Qtrs
Gain on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$1.00K	USD	3 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-49.00K	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.45M	USD	3 Qtrs
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$5.55M	USD	3 Qtrs
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$3.68M	USD	1 Quarter
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$608.00K	USD	3 Qtrs
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$3.00K	USD	1 Quarter
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$-1.47M	USD	3 Qtrs
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$700.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$697.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.63M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$3.83M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$1.86M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.73M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$306.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$8.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$387.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.87M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$753.00K	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.42M	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$9.27M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-615.00K	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-536.00K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$8.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-30.82M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-61.04M	USD	3 Qtrs
Purchases of available-for-sale marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$68.73M	USD	3 Qtrs
Purchases of available-for-sale marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$108.53M	USD	3 Qtrs
Sales of available-for-sale marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$17.09M	USD	3 Qtrs
Maturities of available-for-sale marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$11.55M	USD	3 Qtrs
Maturities of available-for-sale marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$45.00M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$683.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.82M	USD	3 Qtrs
Purchase of research and development license	`PaymentsToAcquireResearchAndDevelopmentLicense`	$10.00M	USD	3 Qtrs
Cash paid, net of cash acquired for the Rhythm Xience Acquisition	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-70.87M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-54.26M	USD	3 Qtrs
Proceeds from issuance of debt and warrants	`ProceedsFromIssuanceOfDebtAndWarrants`	$77.00M	USD	3 Qtrs
Repayment of debt	`ProceedsFromRepaymentsOfDebt`	$-15.00M	USD	3 Qtrs
Payment of issuance and extinguishment costs related to debt	`PaymentsOfDebtExtinguishmentCosts`	$2.33M	USD	3 Qtrs
Payment of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$2.64M	USD	3 Qtrs
Proceeds from issuance of convertible preferred stock, net of issuance costs	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$66.57M	USD	3 Qtrs
Proceeds from issuance of common stock upon IPO, net of issuance costs	`ProceedsFromIssuanceInitialPublicOffering`	$166.29M	USD	3 Qtrs
Proceeds from issuance of common stock upon IPO, net of issuance costs	`ProceedsFromIssuanceInitialPublicOffering`	$166.30M	USD	Point-in-time
Proceeds from stock options exercises	`ProceedsFromStockOptionsExercised`	$350.00K	USD	3 Qtrs
Proceeds from stock options exercises	`ProceedsFromStockOptionsExercised`	$76.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$164.00M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$126.31M	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-50.00K	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$143.00K	USD	3 Qtrs
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$48.85M	USD	3 Qtrs
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$24.57M	USD	3 Qtrs
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.45M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$34.34M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.78M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.45M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$34.34M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.78M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$4.65M	USD	3 Qtrs
Cash paid for interest	`InterestPaid`	$3.53M	USD	3 Qtrs
Issuance of Series D convertible preferred stock for 2018 Convertible Notes and 2019 Convertible Notes	`IssuanceOfSeriesDConvertiblePreferredStockFor2018ConvertibleNotesAnd2019ConvertibleNotes`	$68.48M	USD	3 Qtrs
Issuance of Series D convertible preferred stock for Biotronik asset purchase	`IssuanceOfSeriesDConvertiblePreferredStockForBiotroniksAssetPurchase`	$5.00M	USD	3 Qtrs
Issuance of Series D convertible preferred stock for Rhythm Xience Acquisition	`IssuanceOfSeriesDConvertiblePreferredStockForRhythmXienceAcquisition`	$2.20M	USD	3 Qtrs
Change in unrealized (gain) loss on marketable securities	`UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments`	$-47.00K	USD	3 Qtrs
Change in unrealized (gain) loss on marketable securities	`UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments`	$50.00K	USD	3 Qtrs
Warrants issued in conjunction with OrbiMed debt	`WarrantsIssuedInConjunctionWithOrbrimedDebt`	$872.00K	USD	3 Qtrs
Right-of-use assets exchanged for operating lease liabilities	`RightofuseassetsExchangedForOperatingLeaseLiabilities`	$2.98M	USD	3 Qtrs
Accrued purchase of research and development-license	`AccruedPurchaseOfResearchAndDevelopmentLicense`	$5.00M	USD	3 Qtrs
Unpaid purchases of property and equipment	`UnpaidPurchasesOfPropertyPlantAndEquipment`	$35.00K	USD	3 Qtrs
Unpaid purchases of property and equipment	`UnpaidPurchasesOfPropertyPlantAndEquipment`	$88.00K	USD	3 Qtrs
Conversion of convertible preferred stock into common stock upon IPO	`ConversionOfStockAmountConverted1`	$260.56M	USD	3 Qtrs
Reclassification of warrant liability to stockholders' equity	`ReclassificationOfWarrantLiabilityToStockholdersEquity`	$14.47M	USD	1 Quarter
Reclassification of warrant liability to stockholders' equity	`ReclassificationOfWarrantLiabilityToStockholdersEquity`	$14.47M	USD	3 Qtrs

Stockholders Equity 38 line items

Line Item	Tag	Value	Unit	Period
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$152.64M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-131.82M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-263.97M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-206.71M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-175.45M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-9.00K	USD	1 Quarter
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$47.00K	USD	3 Qtrs
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-50.00K	USD	3 Qtrs
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$40.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$78.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-57.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-45.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$147.00K	USD	3 Qtrs
Conversion of convertible preferred stock into common stock upon IPO	`ReclassificationsOfTemporaryToPermanentEquity`	$260.56M	USD	3 Qtrs
Conversion of convertible preferred stock into common stock upon IPO	`ReclassificationsOfTemporaryToPermanentEquity`	$260.56M	USD	1 Quarter
Issuance of common stock for cash, net of issuance costs of $16,361	`StockIssuedDuringPeriodValueIssuedForServices`	$166.29M	USD	3 Qtrs
Issuance of common stock for cash, net of issuance costs of $16,361	`StockIssuedDuringPeriodValueIssuedForServices`	$166.29M	USD	1 Quarter
Reclassification of warrant liability to stockholders' equity	`ReclassificationOfWarrantLiabilityToStockholdersEquity`	$14.47M	USD	1 Quarter
Reclassification of warrant liability to stockholders' equity	`ReclassificationOfWarrantLiabilityToStockholdersEquity`	$14.47M	USD	3 Qtrs
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$350.00K	USD	3 Qtrs
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$145.00K	USD	1 Quarter
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$19.00K	USD	1 Quarter
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$76.00K	USD	3 Qtrs
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$6.37M	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$812.00K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$2.17M	USD	3 Qtrs
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$9.27M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-31.29M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-32.09M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-77.12M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-72.58M	USD	3 Qtrs
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$152.64M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-131.82M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-263.97M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-206.71M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-175.45M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.